头皮脑电图上无创检测海马癫痫样活动
本研究利用141名受试者的脑电数据训练并验证深度学习网络HEAnet,用于从标准头皮脑电图检测海马癫痫样活动。在独立验证集中,HEAnet区分颞叶癫痫与健康对照的AUC ROC达0.88和0.95,并将专家诊断颞叶癫痫的灵敏度从50%~58%提高至63%~67%。
要点
- HEAnet在头皮脑电图上检测海马癫痫样活动,单事件检测AUC ROC为0.89。
- 外部验证中区分颞叶癫痫与健康对照的AUC ROC分别为0.88和0.95。
- HEAnet联合专家判读将颞叶癫痫诊断灵敏度从50%~58%提高至63%~67%。
核心结论
- HEAnet提供了一种无创、定量且具有临床相关性的海马高兴奋性生物标志物。
研究设计与样本
- 诊断研究,2008年至2021年在马萨诸塞州总医院和布莱根妇女医院两个学术医院的三级癫痫中心进行。
- 纳入141名受试者(97例颞叶癫痫患者和44名无癫痫健康对照),年龄12至78岁,排除有颅内手术史者。
- 使用同步颅内脑电和/或头皮脑电数据训练和验证深度神经网络HEAnet。
主要发现
- 数据集1包含51例颞叶癫痫患者(平均[SD]年龄40.7[15.9]岁;30名男性[59%])的同步头皮和颅内电极记录,生成972095个阳性海马癫痫样活动训练样本和22762个专家标注测试样本。
- 数据集1单事件检测:HEAnet平均(SD)AUC ROC为0.89(0.01),平均(SD)AUC PR为0.39(0.03)。
- 数据集2(马萨诸塞州总医院;24例颞叶癫痫和20名健康对照;平均[SD]年龄42.3[16.2]岁;17名男性[39%])中,HEAnet区分颞叶癫痫与健康对照的AUC ROC为0.88,癫痫侧别预测准确率为100%。
- 数据集3(布莱根妇女医院;22例颞叶癫痫和24名健康对照;平均[SD]年龄43.0[14.4]岁;20名男性[43%])中,HEAnet区分颞叶癫痫与健康对照的AUC ROC为0.95,癫痫侧别预测准确率为92%。
- 在不降低特异度的情况下,将HEAnet加入人类专家脑电判读,使诊断颞叶癫痫的灵敏度从50%~58%提高至63%~67%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The hippocampus is a highly epileptogenic brain region, yet over 90% of hippocampal epileptiform activity (HEA) cannot be identified on scalp electroencephalogram (EEG) by human experts. Currently, detection of HEA requires intracranial electrodes, which limits our understanding of the role of HEA in brain diseases. OBJECTIVE: To develop and validate a machine learning algorithm that accurately detects HEA from a standard scalp EEG, without the need for intracranial electrodes. DESIGN, SETTING, AND PARTICIPANTS: In this diagnostic study, conducted from 2008 to 2021, EEG data were used from patients with temporal lobe epilepsy (TLE) and healthy controls (HCs) to train and validate a deep neural network, HEAnet, to detect HEA on scalp EEG. Participants were evaluated at tertiary-level epilepsy centers at 2 academic hospitals: Massachusetts General Hospital (MGH) or Brigham and Women's Hospital (BWH). Included in the study were patients aged 12 to 78 years with a clinical diagnosis of TLE and HCs without epilepsy. Patients with TLE and HCs with a history of intracranial surgery were excluded from the study. EXPOSURES: Simultaneous intracranial EEG and/or scalp EEG. MAIN OUTCOMES AND MEASURES: Performance was assessed using cross-validated areas under the receiver operating characteristic curve (AUC ROC) and precision-recall curve (AUC PR) and additional clinically relevant metrics. RESULTS: HEAnet was trained and validated using data sets that were derived from a convenience sample of 141 eligible participants (97 with TLE and 44 HCs without epilepsy) whose retrospective EEG data were readily available. Data set 1 included the simultaneous scalp EEG and intracranial electrode recordings of 51 patients with TLE (mean [SD] age, 40.7 [15.9] years; 30 men [59%]) at MGH. An automatically generated training data set with 972 095 positive HEA examples was created, in addition to a held-out expert-annotated testing data set with 22 762 positive HEA examples. HEAnet's performance was validated on 2 independent scalp EEG data sets: (1) data set 2 (at MGH; 24 patients with TLE and 20 HCs; mean [SD] age, 42.3 [16.2] years; 17 men [39%]) and (2) data set 3 (at BWH; 22 patients with TLE and 24 HCs; mean [SD] age, 43.0 [14.4] years; 20 men [43%]). For single-event detection of HEA on data set 1, HEAnet achieved a mean (SD) AUC ROC of 0.89 (0.01) and a mean (SD) AUC PR of 0.39 (0.03). On external validation with data sets 2 and 3, HEAnet accurately distinguished TLE from HC (AUC ROC of 0.88 and 0.95, respectively) and predicted epilepsy lateralization with 100% and 92% accuracy, respectively. HEAnet tracked dynamic changes in HEA in response to seizure medication adjustments and performed comparably with human experts in diagnosing TLE from 1-hour scalp EEG recordings, diagnosing TLE in several individuals that experts missed. Without reducing specificity, addition of HEAnet to human expert EEG review increased sensitivity for diagnosing TLE in humans from 50% to 58% to 63% to 67%. CONCLUSIONS AND RELEVANCE: Results of this diagnostic study suggest that HEAnet provides a novel, noninvasive, quantitative, and clinically relevant biomarker of hippocampal hyperexcitability in humans.
引用
- Abou Jaoude M, Jacobs CS, Sarkis RA, et al. Noninvasive Detection of Hippocampal Epileptiform Activity on Scalp Electroencephalogram. JAMA Neurol. 2022. PMID: 35499837. doi:10.1001/jamaneurol.2022.0888
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。